Top Cancer companies by Market Cap
Browse the largest Cancer companies in the world ranked by their Market Capitalization. Global Cancer Companies market cap is $242.07B.
1 Sept 2024, 10:22 UTC
Companies: 361
🇺🇸301 |  | $3.43 | 3.00% | 12.81M | -27.05% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸302 |  | $0.07 | 0.00% | 12.73M | -38.33% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇺🇸303 |  | $2.72 | 3.03% | 12.44M | 272.60% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇦304 |  | $0.79 | 6.76% | 12.34M | -86.61% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸305 |  | $2.52 | 7.23% | 12.31M | -12.80% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸306 |  | $0.99 | 2.06% | 12.23M | 115.22% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸307 |  | $4.11 | 0.00% | 12.16M | -61.94% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸308 |  | $0.18 | 5.88% | 11.59M | -92.24% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸309 |  | $1.02 | -0.97% | 10.91M | -46.60% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸310 |  | $1.15 | 5.50% | 10.81M | 64.29% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸311 |  | $0.12 | -6.17% | 10.75M | -87.74% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇮🇱312 |  | $0.04 | -1.31% | 10.28M | -52.06% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺313 |  | $0.00 | 0.00% | 9.73M | -12.50% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇦314 |  | $0.07 | -36.27% | 9.51M | -29.90% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸315 |  | $1.58 | 0.64% | 9.38M | -37.55% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪316 |  | $0.13 | 2.58% | 9.20M | -21.96% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇳🇴317 |  | $0.26 | 1.29% | 8.88M | -97.72% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸318 |  | $1.53 | 0.66% | 8.22M | -60.26% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸319 |  | $0.02 | 0.00% | 7.98M | -50.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪320 |  | $0.11 | 5.45% | 7.96M | -42.86% | Underperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
🇺🇸321 |  | $0.37 | 0.00% | 7.78M | -49.25% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇬🇧322 |  | $0.09 | 0.00% | 7.52M | -19.12% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸323 |  | $1.03 | 0.00% | 7.46M | 71.67% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇬🇧324 |  | $0.02 | 0.00% | 7.40M | -20.51% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇩🇪325 |  | $0.35 | -2.48% | 7.21M | -69.74% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸326 |  | $0.14 | -6.76% | 7.19M | -4.83% | Underperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
🇺🇸327 |  | $0.36 | 1.69% | 6.78M | 92.51% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪328 |  | $0.03 | -1.88% | 6.67M | -6.27% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸329 |  | $1.66 | -3.49% | 6.54M | 150.76% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇳🇴330 |  | $0.17 | 2.78% | 6.51M | -17.23% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸331 |  | $1.43 | 0.70% | 6.47M | -20.11% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇬🇧332 |  | $0.05 | 2.70% | 6.44M | -47.59% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇦333 |  | $0.05 | 0.00% | 6.14M | 70.07% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪334 |  | $0.10 | -0.46% | 5.96M | 112.87% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸335 |  | $1.05 | 0.00% | 5.51M | 72.84% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸336 |  | $0.05 | -2.24% | 5.44M | -74.53% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸337 |  | $0.57 | -7.32% | 5.13M | -71.07% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇬338 |  | $0.01 | 0.00% | 5.05M | -23.08% | Underperform S&P500 YTD Benchamark | ⚕️💻 Healthtech | - |
🇨🇦339 |  | $0.07 | 0.00% | 4.92M | 11.76% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇮🇱340 |  | $0.03 | 0.00% | 4.34M | -92.40% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸341 |  | $1.30 | -0.76% | 4.15M | -7.14% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸342 |  | $1.78 | -1.11% | 4.00M | -26.45% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪343 |  | $0.09 | -5.40% | 3.86M | -50.79% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸344 |  | $0.38 | 13.98% | 3.60M | -97.98% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇭345 |  | $0.06 | 4.00% | 3.59M | 23.81% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸346 |  | $0.01 | 0.00% | 3.59M | 45.83% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇬🇧347 |  | $0.03 | -6.82% | 3.56M | -65.25% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪348 |  | $0.17 | -8.21% | 3.45M | -61.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇦349 |  | $0.41 | 2.00% | 3.24M | -83.87% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇩🇪350 |  | $0.18 | -0.37% | 3.12M | -31.34% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪351 |  | $0.19 | 0.00% | 3.11M | -27.41% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇺🇸352 |  | $0.06 | 0.00% | 2.81M | 0.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸353 |  | $0.09 | 0.00% | 2.65M | 260.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸354 |  | $2.09 | 0.00% | 2.63M | 111.11% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇬🇧355 |  | $0.01 | 0.00% | 2.53M | -56.25% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇦356 |  | $0.01 | -33.33% | 2.51M | -60.00% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇬🇧357 |  | $0.01 | 0.00% | 1.68M | -45.71% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇦358 |  | $0.01 | 0.00% | 1.10M | -47.02% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸359 |  | $1.05 | 0.96% | 1.07M | -61.25% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸360 |  | $0.18 | 13.44% | 1.07M | -67.30% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
